Related references
Note: Only part of the references are listed.Calcitonin gene-related peptide (CGRP) levels during glyceryl trinitrate (GTN)-induced headache in healthy volunteers
C. Kruuse et al.
CEPHALALGIA (2010)
Calcitonin gene-related peptide receptor inhibition reduces neuronal activity induced by prolonged increase in nitric oxide in the rat spinal trigeminal nucleus
S. Koulchitsky et al.
CEPHALALGIA (2009)
Inhibitory effect of BIBN4096BS, CGRP8-37, a CGRP antibody and an RNA-Spiegelmer on CGRP induced vasodilatation in the perfused and non-perfused rat middle cerebral artery
L. Edvinsson et al.
BRITISH JOURNAL OF PHARMACOLOGY (2007)
BIBN4096BS antagonizes human α-calcitonin gene related peptide-induced headache and extracerebral artery dilatation
KA Petersen et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2005)
CGRP release and c-fos expression within trigeminal nucleus caudalis of the rat following glyceryltrinitrate infusion
N Offenhauser et al.
CEPHALALGIA (2005)
Calcitonin gene-related peptide antagonists as treatments of migraine and other primary headaches
PJ Goadsby
DRUGS (2005)
Calcitonin gene-related peptide receptor antagonist BIBN4096BS for the acute treatment of migraine
J Olesen et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Biphasic response to nitric oxide of spinal trigeminal neurons with meningeal input in rat-possible implications for the pathophysiology of headaches
S Koulchitsky et al.
JOURNAL OF NEUROPHYSIOLOGY (2004)
Safety, tolerability and pharmacokinetics of BIBN4096BS, the first selective small molecule calcitonin gene-related peptide receptor antagonist, following single intravenous administration in healthy volunteers
M Iovino et al.
CEPHALALGIA (2004)
Glyceryl trinitrate triggers premonitory symptoms in migraineurs
SK Afridi et al.
PAIN (2004)
The effect of propranolol on glyceryltrinitrate-induced headache and arterial response
JF Tvedskov et al.
CEPHALALGIA (2004)
A double-blind study of SB-220453 (Tonerbasat) in the glyceryltrinitrate (GTN) model of migraine
JF Tvedskov et al.
CEPHALALGIA (2004)
No effect of eletriptan administration during the aura phase of migraine
J Olesen et al.
EUROPEAN JOURNAL OF NEUROLOGY (2004)
Nitric oxide releases calcitonin-gene-related peptide from rat dura mater encephali promoting increases in meningeal blood flow
T Strecker et al.
JOURNAL OF VASCULAR RESEARCH (2002)
CGRP may play a causative role in migraine
LH Lassen et al.
CEPHALALGIA (2002)
Effect of the CGRP receptor antagonist BIBN4096BS in human cerebral, coronary and omental arteries and in SK-N-MC cells
L Edvinsson et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2002)
Release of calcitonin gene-related peptide (CGRP) from guinea pig dura mater in vitro is inhibited by sumatriptan but unaffected by nitric oxide
CT Eltorp et al.
CEPHALALGIA (2000)
Share Paper
